info

Tuesday 8 May 2018

Unenhanced Chest Computerized Tomography Assisted Sentinel Lymph Node Biopsy Could be a Highly Reliable Option for Only Methylene Blue Available Breast Cancer Patients




Chinese incidence of breast cancer has increased remarkably with the socioeconomic development, particularly in eastern coastal areas, and it has been expected to approach more than 100 cases per 100000 women aged 55~69 years by 2021. Whereas, benefitting from systemic therapy, the invasiveness of surgical treatment has been largely controlled. Clinical trials have revolutionized the pattern of clinical practice. Mastectomy and Axillary Lymph Node Dissection (ALND) were both profoundly proven not to improve survival and Quality of Life (QOL) when comparing with Breast-Conserving Therapy (BCT) and Sentinel Lymph Node Biopsy (SLNB) [3,4]. National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 and other trials identified that SLNB could not only reduce the surgical morbidities, but could also be reliable for axillary staging of clinically lymph node negative (cN0) breast cancer.

SNB has become the standard of care in patients with cN0 disease. Although blue dye and radioisotope (RI) combined lymphatic mapping was well established as a standard procedure to limit FNR  but the optimal protocol for SLNB is still under investigation. In many Japanese hospitals, due to the lack of RI, contrast enhanced CT Lymphography (CT-LG) has been routinely used to stage the axilla accurately with dye-only SLNB. It was concluded that using the only size criterion by CT-LGor MRI alone to diagnose SLNs was not sufficient. No matter what contrast regimen used, the cost and procedure of the technique they used were not practical in China.

Based on previous studies on ultrasonography and CT-LG, metastatic nodes have several abnormal signs. In our daily wok, US-guided Core Needle Biopsy (CNB) and unenhanced chest CT have routinely been preoperatively adopted to evaluate node status and triage the patients. Because of unavailable RI and limited financial support in our country, most of patients, especially who live in remote rural areas, must receive more unnecessary ALND. In this context, we conduct this research to evaluate an unenhanced chest CT assisted method for SLNB and provide an alternative option for the given population.

No comments:

Post a Comment

An Evaluation of the Role of fMRI in Patients with Lower Urinary Tract Dysfunction

                                                 https://www.austinpublishinggroup.com/urology/ Patientswith Lower Urinary Tr...